PQRI
This article was originally published in The Tan Sheet
Executive Summary
International Pharmaceutical Aerosol Consortium will collaborate with Product Quality Research Institute on issues concerning chemistry, manufacturing and control requirements for oral and nasal inhalation products, institute reps announce at Dec. 12 briefing marking PQRI's one-year anniversary. Institute also is considering an FDA request to examine drug counterfeiting issues and expects to make recommendations to agency next year on changes in blend uniformity testing requirements. PQRI is a joint effort between industry, academia and FDA to conduct research that generates scientific support for regulatory policy (1"The Tan Sheet" Oct. 11, 1999, p. 9)
You may also be interested in...
PQRI Working Group To Study Necessity Of Blend Uniformity Testing
The Product Quality Research Institute is recruiting volunteers for a working group that will examine whether blend uniformity testing ensures end product quality, FDA and industry officials announced at the Consumer Healthcare Products Association's Manufacturing Controls Seminar in Philadelphia Oct. 7.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands